For instance, Lamp2b-IL-3 expressing exosome was developed to target chronic myeloid leukemia (CML) cells preferentially as they overexpress IL-3 receptors (Bellavia et al., 2017). This evidence concerns the gene IL3 and chronic myelogenous leukemia, BCR-ABL1 positive.